Drug profile · INN
gadoteridol
PROHANCE
gadoteridol (PROHANCE) is a diagnostic agent. Route of administration: injection. Current US regulatory status: approved.
FDA: approved
US status approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — gadoteridol
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
gadoteridol (PROHANCE) is a diagnostic agent. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN gadoteridol
Brand PROHANCE
Mechanism Diagnostic agent
Route INJECTION
Formulation INJECTABLE
Mechanism of action
Diagnostic agent
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Frequently asked questions
What is gadoteridol?
gadoteridol (PROHANCE) is a diagnostic agent. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for gadoteridol?
PROHANCE is a marketed brand name for gadoteridol. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of gadoteridol?
gadoteridol has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.